Document:

Index Options Contract Schedule

          

    

    

    Owner:          [John Doe] Contract Number:                 [??687456]

    [Joint Owner:[Jane Doe]] Issue Date:                           [04/15/10]

    Annuitant:     [John Doe] Scheduled Annuity Date:     [04/15/65]

    Annuitant’s Age[35 Male]

    and Gender

    

    

    

    

    Allocation Guidelines:

    [1. Currently, you can select up to [5] of the Index Protection Strategy Index Options.

    2. Currently, you can select up to [5] of the Index Performance Strategy Index Options.

    3. Currently, you can select up to [5] of the Index Guard Strategy Index Options.

    4. Currently, you can select up to [5] of the Index Precision Strategy Index Options.

    5. Currently, you can select up to a maximum of [15] Index Options.

    6. Allocations must be made in whole percentages.]

    

    

    Index Options:

    [Index Protection Strategy Index Options

    	
            Index

          	
            Minimum Declared Protection Strategy Credit for all Index Years

          	
            Term

          
	
            [S&P 500® Index

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Nasdaq-100® Index

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Russell 2000® Index

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [EURO STOXX 50®

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [iShares® MSCI Emerging Markets ETF

          	
            [0.10]%

          	
            [1 Index Year]]]

          

    

    

    [Index Performance Strategy Index Options

    	
            Index

          	
            Buffer for all Terms

          	
            Minimum Cap for all Terms

          	
            Term

          
	
            [S&P 500® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Nasdaq-100® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Russell 2000® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [EURO STOXX 50®

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [iShares® MSCI Emerging Markets ETF

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [S&P 500® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [3 Index Years]]

          
	
            [Nasdaq-100® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [3 Index Years]]

          
	
            [Russell 2000® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [3 Index Years]]

          
	
            [EURO STOXX 50®

          	
            [10.00]%

          	
            [0.10]%

          	
            [3 Index Years]]

          
	
            [iShares® MSCI Emerging Markets ETF

          	
            [10.00]%

          	
            [0.10]%

          	
            [3 Index Years]]]

          

    

    

    
      
        S40877-NF-04                                                                           [Admin. Tracking Identifier]

      

      
        

      

    

    

    

    	
            Index Options Contract
                Schedule continued from the
                previous page

          

    [Index Guard Strategy Index Options

    	
            Index

          	
            Floor for all Index Years

          	
            Minimum Cap for all Index Years

          	
            Term

          
	
            [S&P 500® Index

          	
            [-10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Nasdaq-100® Index

          	
            [-10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Russell 2000® Index

          	
            [-10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [EURO STOXX 50®

          	
            [-10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [iShares® MSCI Emerging Markets ETF

          	
            [-10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]]

          

    

    

    

    

    

    

    [Index Precision Strategy Index Options

    	
            Index

          	
            Buffer for all Index Years

          	
            Minimum Precision Rate for all Index Years

          	
            Term

          
	
            [S&P 500® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Nasdaq-100® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [Russell 2000® Index

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [EURO STOXX 50®

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]

          
	
            [iShares® MSCI Emerging Markets ETF

          	
            [10.00]%

          	
            [0.10]%

          	
            [1 Index Year]]]

          

    

    

    The indexes do not reflect the dividends paid on the stocks underlying the market indexes.

    
      
        S40877-NF-04                                                                           [Admin. Tracking Identifier]

      

      
        

      

    

    

    

    

    

    

    

    	
            Index Options Contract
                Schedule continued from the
                previous page

          

    

    

    [The S&P 500® Index is comprised of 500 stocks representing major U.S. industrial sectors.

    

    

    S&P® is a registered trademark of Standard & Poor’s Financial Services LLC (“S&P”). This trademark has been licensed for use by
      S&P Dow Jones Indices LLC. S&P marks are trademarks of S&P. These trademarks have been sublicensed for certain purposes by Allianz Life Insurance Company of North America (“Allianz”). The S&P 500® Index (“the Index”) is a product of
      S&P Dow Jones Indices LLC and/or its affiliates and have been licensed for use by Allianz.

    

    

    Allianz products are not sponsored, endorsed, sold, or promoted by S&P Dow Jones Indices LLC, Dow Jones, S&P, or any of their
      respective affiliates (collectively, “S&P Dow Jones Indices”). S&P Dow Jones Indices make no representation or warranty, express or implied, to the owners of the Allianz products or any member of the public regarding the advisability of
      investments generally or in Allianz products particularly or the ability of the Index and Average to track general market performance. S&P Dow Jones Indices’ only relationship to Allianz with respect to the Index and Average is the licensing of
      the Index and Average and certain trademarks, service marks, and/or trade names of S&P Dow Jones Indices and/or its third-party licensors. The Index and Average are determined, composed, and calculated by S&P Dow Jones Indices without regard
      to Allianz or the products. S&P Dow Jones Indices have no obligation to take the needs of Allianz or the owners of the products into consideration in determining, composing, or calculating the Index and Average. S&P Dow Jones Indices are not
      responsible for and have not participated in the design, development, pricing, and operation of the products, including the calculation of any interest payments or any other values credited to the products. S&P Dow Jones Indices have no
      obligation or liability in connection with the administration, marketing, or trading of products. There is no assurance that investment products based on the Index and Average will accurately track index performance or provide positive investment
      returns. S&P Dow Jones Indices LLC and its subsidiaries are not investment advisors. Inclusion of a security or futures contract within an index is not a recommendation by S&P Dow Jones Indices to buy, sell, or hold such security or futures
      contract, nor is it considered to be investment advice. Notwithstanding the foregoing, CME Group Inc. and its affiliates may independently issue and/or sponsor financial products unrelated to products currently being issued by Allianz, but which may
      be similar to and competitive with Allianz products. In addition, CME Group Inc., an indirect minority owner of S&P Dow Jones Indices LLC, and its affiliates may trade financial products which are linked to the performance of the Index and
      Average. It is possible that this trading activity will affect the value of the products.

    

    

    S&P DOW JONES INDICES DO NOT GUARANTEE THE ADEQUACY, ACCURACY, TIMELINESS, AND/OR THE COMPLETENESS OF THE INDEX AND AVERAGE OR ANY DATA
      RELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC COMMUNICATIONS) WITH RESPECT THERETO. S&P DOW JONES INDICES SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY ERRORS,
      OMISSIONS, OR DELAYS THEREIN. S&P DOW JONES INDICES

    

    

    MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIM ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE
      OR AS TO RESULTS TO BE OBTAINED BY ALLIANZ, OWNERS OF THE PRODUCTS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE INDEX AND AVERAGE OR WITH RESPECT TO ANY DATA RELATED THERETO. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT WHATSOEVER SHALL
      S&P DOW JONES INDICES BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST TIME, OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBILITY OF
      SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE. THERE ARE NO THIRD-PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTS BETWEEN S&P DOW JONES INDICES AND ALLIANZ OTHER THAN THE LICENSORS OF S&P DOW JONES INDICES.]

    

    

    [The NASDAQ-100 Index® includes 100 of the largest domestic and international non-financial securities listed on The NASDAQ Stock Market®
      based on market capitalization.

    

    

    The Product(s) is not sponsored, endorsed, sold or promoted by Nasdaq, Inc. or its affiliates (Nasdaq, with its affiliates, are referred to
      as the “Corporations”).  The Corporations have not passed on the legality or suitability of, or the accuracy or adequacy of descriptions and disclosures relating to, the Product(s).  The Corporations make no representation or warranty, express or
      implied to the owners of the Product(s) or any member of the public regarding the advisability of investing in securities generally or in the Product(s) particularly, or the ability of the Nasdaq-100 Index® to track general stock market performance. 
      The Corporations' only relationship to Allianz Life Insurance Company of North America (“Licensee”) is in the licensing of the NASDAQ®, and Nasdaq-100 Index® registered trademarks, and certain trade names of the Corporations and the use of the
      Nasdaq-100 Index® which is determined, composed and calculated by NASDAQ without regard to Licensee or the Product(s).  Nasdaq has no obligation to take the needs of the Licensee or the owners of the Product(s) into consideration in determining,
      composing or calculating the Nasdaq-100 Index®.  The Corporations are not responsible for and have not participated in the determination of the timing of, prices at, or quantities of the Product(s) to be issued or in the determination or calculation
      of the equation by which the Product(s) is to be converted into cash.  The Corporations have no liability in connection with the administration, marketing or trading of the Product(s).

    
      
        S40877-NF-04                                                                           [Admin. Tracking Identifier]

      

      
        

      

    

    

    

    

    

    	
            Index Options Contract
                Schedule  continued from the previous page

          

    THE CORPORATIONS DO NOT GUARANTEE THE ACCURACY AND/OR UNINTERRUPTED CALCULATION OF THE NASDAQ-100 INDEX® OR ANY DATA INCLUDED THEREIN.  THE
      CORPORATIONS MAKE NO WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE PRODUCT(S), OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE NASDAQ-100 INDEX® OR ANY DATA INCLUDED THEREIN.  THE CORPORATIONS MAKE NO EXPRESS
      OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE NASDAQ-100 INDEX® OR ANY DATA INCLUDED THEREIN.  WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL
      THE CORPORATIONS HAVE ANY LIABILITY FOR ANY LOST PROFITS OR SPECIAL, INCIDENTAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL DAMAGES, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.]

    

    

    [The Russell 2000® Index is an equity index that measures the performance of the 2,000 smallest companies in the Russell 3000® Index, which
      is made up of 3, 000 of the biggest U.S. stocks.  The Russell 2000® Index is constructed to provide a comprehensive and unbiased small-cap barometer and is completely reconstituted annually to ensure larger stocks do not affect the performance and
      characteristics of the true small-cap index.

    

    

    The Russell 2000® Index (the “Index”) is a trademark of Frank Russell Company (“Russell”) and has been licensed for use by Allianz Life
      Insurance Company of North America (“Allianz”). Allianz products are not in any way sponsored, endorsed, sold or promoted by Russell or the London Stock Exchange Group companies (“LSEG”) (together the “Licensor Parties”) and none of the Licensor
      Parties make any claim, prediction, warranty or representation whatsoever, expressly or impliedly, either as to (i) the results to be obtained from the use of the Index (upon which the Allianz product is based), (ii) the figure at which the Index is
      said to stand at any particular time on any particular day or otherwise, or (iii) the suitability of the Index for the purpose to which it is being put in connection with the Allianz product. None of the Licensor Parties have provided or will provide
      any financial or investment advice or recommendation in relation to the Index to Allianz or to its clients. The Index is calculated by Russell or its agent. None of the Licensor Parties shall be (a) liable (whether in negligence or otherwise) to any
      person for any error in the Index or (b) under any obligation to advise any person of any error therein.]

    

    

    [The EURO STOXX 50®, Europe's leading Blue-chip index for the Eurozone, provides a blue-chip representation of supersector leaders in the
      Eurozone.  The index covers 50 stocks from 12 Eurozone countries: Austria, Belgium, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain.

    

    

    STOXX Limited, Deutsche Börse Group and their licensors, research partners or data providers have no relationship to Allianz Life Insurance
      Company of North America (“Allianz”), other than the licensing of the EURO STOXX 50® and the related trademarks for use in connection with Allianz products.

    STOXX, Deutsche Börse Group and their licensors, research partners or data providers do not:

    • sponsor, endorse, sell or promote Allianz products.

    • recommend that any person invest in Allianz products or any other securities.

    • have any responsibility or liability for or make any decisions about the timing, amount or pricing of Allianz products.

    • have any responsibility or liability for the administration, management or marketing of Allianz products.

    • consider the needs of Allianz products or the owners of Allianz products in determining, composing or calculating the EURO STOXX 50 or have
      any obligation to do so.

    STOXX, Deutsche Börse Group and their licensors, research partners or data providers give no warranty, and exclude any
      liability (whether in negligence or otherwise), in connection with the Allianz products or their performance.

    STOXX does not assume any contractual relationship with the purchasers of Allianz products or any other third parties.

    Specifically,

    • STOXX, Deutsche Börse Group and their licensors, research partners or data providers do not give any warranty, express or implied, and
      exclude any liability about:

    • The results to be obtained by Allianz products, the owner of Allianz products or any other person in connection with the use of the EURO
      STOXX 50 and the data included in the EURO STOXX 50;

    • The accuracy, timeliness, and completeness of the EURO STOXX 50 and its data;

    • The merchantability and the fitness for a particular purpose or use of the EURO STOXX 50 and its data;

    • The performance of Allianz products generally.

    • STOXX, Deutsche Börse Group and their licensors, research partners or data providers give no warranty and exclude any liability, for any
      errors, omissions or interruptions in the EURO STOXX 50 or its data;

    • Under no circumstances will STOXX, Deutsche Börse Group or their licensors, research partners or data providers be liable (whether in
      negligence or otherwise) for any lost profits or indirect, punitive, special or consequential damages or losses, arising as a result of such errors, omissions or interruptions in the [relevant index] or its data or generally in relation to Allianz
      products, even in

    circumstances where STOXX, Deutsche Börse Group or their licensors, research partners or data providers are aware that such loss or damage
      may occur.

    

    

    
      
        S40877-NF-04                                                                           [Admin. Tracking Identifier]

      

      
        

      

    

    

    

    

    

    	
            Index Options Contract
                Schedule  continued from the previous page

          

    The licensing Agreement between Allianz and STOXX is solely for their benefit and not for the benefit of the owners of Allianz products or
      any other third parties.]

    

    

    [The iShares® MSCI Emerging Markets ETF distributed by BlackRock Investments, LLC. iShares®, BLACKROCK®, and the corresponding logos are
      registered trademarks of BlackRock, Inc. and its affiliates (“BlackRock”) and are used under license. These trademarks have been licensed for certain purposes by Allianz Life Insurance Company of North America ("Allianz") and its wholly-owned
      subsidiaries. Products offered by Allianz or its wholly-owned subsidiaries are not sponsored, endorsed, sold or promoted by BlackRock, and purchasers of such products do not acquire any interest in the iShares® MSCI Emerging Markets ETF  nor enter
      into any relationship of any kind with BlackRock. BlackRock makes no representations or warranties, express or implied, to the owners of any products offered by Allianz or its wholly-owned subsidiaries, or any member of the public regarding the
      advisability of purchasing a product from Allianz or its wholly-owned subsidiaries. BlackRock has no obligation or liability for any errors, omissions, interruptions or use of the iShares MSCI Emerging Markets ETF or any data related thereto, or with
      the operation, marketing, trading or sale of any products or services offered by Allianz and its wholly-owned subsidiaries.]

    

    

    

    

    

    

    

    

    
      S40877-NF-04                                                                           [Admin. Tracking Identifier]Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase
Agreement (this “Agreement”) is dated as of January 15, 2020, between Coro Global Inc., a Nevada corporation
(the “Company”), and Erik Lutgert, an individual (the “Purchaser”).

 

WHEREAS, subject
to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section
5 of the Securities Act contained in Section 4(a)(2) thereof, the Company desires to issue and sell to the Purchaser, and Purchaser
desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE,
IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1 Definitions.
In addition to the terms defined elsewhere in this Agreement the following terms have the meanings set forth in this Section 1.1:

  

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Closing”
means the closing of the purchase and sale of the Shares pursuant to Section 2.1 hereof.

 

“Closing Date”
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto,
and all conditions precedent to (i) the Purchaser’s obligations to pay the Purchase Price and (ii) the Company’s obligations
to deliver the Shares, in each case, have been satisfied or waived, subject to the provisions of Section 2.1.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“SEC Reports”
shall have the meaning ascribed to such term in Section 3.2(d) hereof.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Shares”
has the meaning ascribed to such term in Section 2.1 hereof.

 

“Trading Day”
means a day on which the principal Trading Market is open for trading.

 

“Trading Market”
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange
or any tier of the OTC Markets operated by the OTC Markets Group, Inc. (or any successors to any of the foregoing).

 

     

     

    

 

“Transaction
Documents” means this Agreement and any other documents executed in connection with the transaction contemplated hereunder.

 

“Transfer
Agent” means Issuer Direct Corporation, the current transfer agent of the Company, and any successor transfer agent of
the Company.

 

ARTICLE II.

PURCHASE AND SALE

 

2.1 Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution
and delivery of this Agreement by the parties hereto, the Company shall sell, and the Purchaser shall purchase, 50,000 shares of
Common Stock (the “Shares”) at $5.00 per share for an aggregate purchase price of $250,000 (the “Purchase
Price”). At or prior to the Closing, the Company and the Purchaser shall deliver the other items set forth in Section
2.2, hereof. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, hereof, the Closing shall occur
at the offices of the Company or such other location as the parties shall mutually agree.

 

2.2 Deliveries.

 

(a) On or
prior to the Closing Date, the Company shall deliver to the Purchaser this Agreement duly executed by the Company. The Company
shall deliver or cause to be delivered to the Purchaser the Shares purchased hereunder to the address set forth on the signature
page hereto within 5 Business Days of the Closing Date.

 

(b) On or prior to
the Closing Date, the Purchaser shall deliver or cause to be delivered to the Company this Agreement duly executed by the Purchaser
and the Purchase Price by wire of immediately available funds.

 

2.3 Closing Conditions.

 

(a) The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

		(i)	the accuracy in all material respects on the Closing Date of the representations and warranties
of the Purchaser contained herein (unless as of a specific date therein in which case they shall be accurate as of such date)

 

		(ii)	all obligations, covenants and agreements of the Purchaser required to be performed at or prior
to the Closing Date shall have been performed; and

 

		(iii)	the delivery by the Purchaser of the item set forth in Section 2.2(b) hereof.

 

(b) The obligation
of the Purchaser hereunder in connection with the Closing are subject to the following conditions being met:

 

		(i)	the accuracy in all material respects when made and on the Closing Date of the representations
and warranties of the Company contained herein (unless as of a specific date therein);

 

		(ii)	all obligations, covenants and agreements of the Company required to be performed at or prior to
the Closing Date shall have been performed;

 

    - 2 -

     

    

 

		(iii)	from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended
by the Commission or the Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities
generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established
on securities whose trades are reported by such service, or on any Trading Market; and

 

		(iv)	the delivery by the Company of the items set forth in Section 2.2(a) hereof.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES

 

3.1 Representations
and Warranties of the Company. The Company hereby makes the following representations and warranties to the Purchaser:

 

(a) The Company is
a corporation, validly existing and in good standing under the laws of Nevada.

 

(b) The Company has
the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and
otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the
Company.

 

(c) The execution,
delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the consummation by it of the
transactions contemplated hereby party do not and will not conflict with or violate any provision of the Company’s articles
of incorporation or other organizational or charter documents. The Shares, upon issuance in accordance with this Agreement, will
be duly issued, fully paid, and nonassessable.

 

3.2 Representations
and Warranties of the Purchaser. The Purchaser hereby represents and warrants as of the date hereof and as of the Closing Date
to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):

 

(a) Authority.
Each Transaction Document to which Purchaser is a party has been duly executed by the Purchaser, and when delivered by the Purchaser
in accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against
it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b) Understandings
or Arrangements. The Purchaser is acquiring the Shares as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Shares. The Purchaser is acquiring
the Shares hereunder in the ordinary course of its business.

 

(c) Purchaser Status.
At the time the Purchaser was offered the Shares, it was, and as of the date hereof it is an “accredited investor”
as defined in Rule 501(a) under the Securities Act.

 

(d) Experience of
the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares,
and has so evaluated the merits and risks of such investment. The Purchaser understands that an investment in the Shares involves
a high degree of risk, including the risks set forth in the Company’s filings with the Commission under the Exchange Act
since January 1, 2018 (the “SEC Reports”). The Purchaser is able to bear the economic risk of an investment in the
Shares and, at the present time, is able to afford a complete loss of such investment.

 

    - 3 -

     

    

 

(e) Access to Information.
The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules
thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and
to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Shares and the
merits and risks of investing in the Shares; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense
that is necessary to make an informed investment decision with respect to the investment.

 

(f) Restricted Securities.
The Purchaser understands that the Shares are restricted securities within the meaning of the Securities Act, have not been registered
under the Securities Act or any state securities laws and may not be transferred or sold except pursuant to an effective registration
statement or an available exemption therefrom.

 

ARTICLE IV.

MISCELLANEOUS

 

4.1 Expenses.
The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any
instruction letter delivered by the Company), stamp taxes and other taxes and duties levied in connection with the delivery of
the Shares to the Purchaser other than income and capital gains taxes of the Purchaser that may be incurred in connection with
the transactions contemplated hereby.

 

4.2 Entire Agreement.
The Transaction Documents contain the entire understanding of the parties with respect to the subject matter hereof and thereof
and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.

 

4.3 Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile or e-mail at the facsimile number or e-mail address set forth on the signature pages attached hereto at or prior
to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or
communication is delivered via facsimile or e-mail at the facsimile number or e-mail address set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth
on the signature pages attached hereto.

 

4.4 Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed
by the Company and the Purchaser. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair
the exercise of any such right.

 

4.5 Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

4.6 Successors and
Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
Neither the Purchaser nor the Company may assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other party (other than by operation of law).

 

    - 4 -

     

    

 

4.7 Governing Law.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of
conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or
proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such action, suit or proceeding
shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

 

4.8 Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Shares.

 

4.9 Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

4.10 Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

4.11 Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy
at law would be adequate.

 

4.12 Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

4.13 Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.

 

4.14 No Third Party
Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth
in Section 4.6 hereof.

 

4.15 Replacement
of Shares. If any certificate or instrument evidencing any Shares is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu
of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Shares.

 

[Signature Pages Follow]

 

    - 5 -

     

    

 

IN WITNESS WHEREOF,
the the undersigned has duly executed this Securities Purchase Agreement as of the date first indicated above.

 

CORO GLOBAL INC.

 

	By:	/s/ J. Mark Goode	 
	Name: 	J. Mark Goode	 
	Title:	Chief Executive Officer	 

 

Address for Notice:

 

78 SW 7th Street

Miami, FL 33130

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

    - 6 -

     

    

 

[PURCHASER SIGNATURE PAGE TO CORO GLOBAL
INC. SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned
has duly executed this Securities Purchase Agreement as of the date first indicated above.

 

	/s/ Erik Lutgert	 
	Erik Lutgert	 

 

Address for Notice:

 

 

 

Address for delivery of Shares (if different
from address for notice):

 

 

 

Social Security #:

 

 

- 7 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]